Malignant hyperthermia
Anaesthetic hypermetabolic crisis · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Life-threatening hypermetabolic reaction to volatile anaesthetics or suxamethonium in susceptible patients, with rising CO2, rigidity, hyperthermia and acidosis.
Red flags
- Unexplained rising end-tidal CO2
- Masseter/generalised rigidity
- Rapidly rising temperature
- Hyperkalaemia and arrhythmia
Assessment
Differential diagnosis
- Thyroid storm
- Neuroleptic malignant/serotonin syndrome
- Sepsis
- Inadequate ventilation
- Phaeochromocytoma
Investigations
- Rising end-tidal CO2 (early sign)
- VBG (mixed acidosis), potassium
- Creatine kinase and myoglobin
- Core temperature
Management
- Stop all volatile agents and suxamethonium immediately
- Call for help and switch to a clean circuit; hyperventilate with 100% oxygen
- Give dantrolene without delay and repeat as needed
- Actively cool the patient
- Treat hyperkalaemia, acidosis and arrhythmia
- ICU care; monitor for rhabdomyolysis and recrudescence
Drugs & doses
Dantrolene (muscle relaxant) - IV 2.5 mg/kg, repeat to effect
Calcium/insulin-dextrose for hyperkalaemia
Active cooling and supportive measures
Disposition
ICU; refer for MH susceptibility testing.
Complications & pitfalls
- Hyperkalaemic arrest
- Rhabdomyolysis and AKI
- DIC
- Recrudescence
Exam pearls
- Rising end-tidal CO2 is often the earliest sign
- Dantrolene must be given early and repeatedly
- Refer for later susceptibility testing and family screening
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.